Onay Meryem, Şanal Baş Sema, Işıker Arda, Akkemik Ümit, Bilir Ayten
Department of Anaesthesiology and Reanimation, Eskişehir Osmangazi University Faculty of Medicine, Eskişehir, Turkey.
Clinic of Anaesthesiology and Reanimation, Kırklareli Training and Research Hospital, Kırklareli, Turkey.
Turk J Anaesthesiol Reanim. 2023 Aug 18;51(4):297-303. doi: 10.4274/TJAR.2023.221140.
Intrathecal morphine is used as an effective component of multimodal analgesia in postoperative analgesia in cesarean section patients. We aimed to analyze the relationship between intrathecal morphine administration and postdural puncture headache (PDPH), pain score and analgesia consumption in the postoperative period, and maternal fetal effects.
One hundred four pregnant women aged ≥18 years (American Society of Anesthesiology physical status I or II, >36 weeks gestation) who were scheduled for elective cesarean section under spinal anaesthesia were included in this study. Spinal anesthesia consisted of bupivacaine with or without morphine (Group M: 10 mg heavy marcaine + 25 mcg fentanyl + 100 mcg morphine; Group F: 10 mg heavy marcaine + 25 mcg fentanyl). The effect of intrathecal morphine on PDPH, postoperative pain score, analgesia consumption, and maternal and fetal effects were recorded for 5 days.
PDPH developed in a total of 33 patients (Group M: 18 and Group F: 15, =0.274). When we evaluated PDPH with the VAS, there was no significant difference between the groups. The postoperative visual analogue scale (VAS) was lower in the morphine group, and no statistically significant difference was found in the VAS 1 hr and VAS 2 hr, whereas the VAS 6 hr and VAS 24 hr were found to be statistically significant. There was no difference in terms of PDPH, the first analgesic requirement and postoperative nausea-vomiting, but meperidine consumption was lower in the morphine group.
Low-dose intrathecal morphine did not affect the incidence of PDPH. It is an effective method that can be used in cesarean section patients without increasing the maternal and fetal side effects from postoperative analgesia.
鞘内注射吗啡是剖宫产患者术后多模式镇痛的有效组成部分。我们旨在分析鞘内注射吗啡与硬膜穿刺后头痛(PDPH)、术后疼痛评分、镇痛药物消耗量以及母婴影响之间的关系。
本研究纳入了104例年龄≥18岁(美国麻醉医师协会身体状况I或II级,孕周>36周)计划在脊髓麻醉下行择期剖宫产的孕妇。脊髓麻醉采用布比卡因加或不加吗啡(M组:10mg重比重布比卡因+25μg芬太尼+100μg吗啡;F组:10mg重比重布比卡因+25μg芬太尼)。记录鞘内注射吗啡对PDPH、术后疼痛评分、镇痛药物消耗量以及母婴影响,为期5天。
共有33例患者发生PDPH(M组:18例,F组:15例,P=0.274)。当我们用视觉模拟评分法(VAS)评估PDPH时,两组之间无显著差异。吗啡组术后视觉模拟量表(VAS)较低,在VAS 1小时和VAS 2小时未发现统计学显著差异,而VAS 6小时和VAS 24小时有统计学显著差异。在PDPH、首次镇痛需求和术后恶心呕吐方面无差异,但吗啡组哌替啶消耗量较低。
低剂量鞘内注射吗啡不影响PDPH的发生率。它是一种可用于剖宫产患者的有效方法,不会增加术后镇痛的母婴副作用。